<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>55(2)</volume><submitter>Volp K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>High mobility group box 1 (HMGB1) is a non-histone chromosomal protein implicated in a variety of biologically important processes, including transcription, DNA repair, V(D)J recombination, differentiation, and development. Overexpression of HMGB1 inhibits apoptosis, arguing that the molecule may act as an antiapoptotic oncoprotein. Indeed, increased expression of HMGB1 has been reported for several different tumour types. In this study, we analysed human colon carcinoma for HMGB1 as well as for c-IAP2 expression levels. c-IAP2 is an antiapoptotic protein which may be upregulated as a consequence of nuclear factor kappaB (NFkappaB) activation via HMGB1.&lt;h4>Methods&lt;/h4>A comparative genomic hybridisation (CGH) database comprising 1645 cases from different human tumour typ</pubmed_abstract><journal>Gut</journal><pagination>234-42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1856519</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.</pubmed_title><pmcid>PMC1856519</pmcid><pubmed_authors>Volp K</pubmed_authors><pubmed_authors>Brezniceanu ML</pubmed_authors><pubmed_authors>Gottel D</pubmed_authors><pubmed_authors>Zornig M</pubmed_authors><pubmed_authors>Brabletz T</pubmed_authors><pubmed_authors>Joos S</pubmed_authors><pubmed_authors>Kirchner T</pubmed_authors><pubmed_authors>Bosser S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.</name><description>&lt;h4>Background&lt;/h4>High mobility group box 1 (HMGB1) is a non-histone chromosomal protein implicated in a variety of biologically important processes, including transcription, DNA repair, V(D)J recombination, differentiation, and development. Overexpression of HMGB1 inhibits apoptosis, arguing that the molecule may act as an antiapoptotic oncoprotein. Indeed, increased expression of HMGB1 has been reported for several different tumour types. In this study, we analysed human colon carcinoma for HMGB1 as well as for c-IAP2 expression levels. c-IAP2 is an antiapoptotic protein which may be upregulated as a consequence of nuclear factor kappaB (NFkappaB) activation via HMGB1.&lt;h4>Methods&lt;/h4>A comparative genomic hybridisation (CGH) database comprising 1645 cases from different human tumour typ</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Feb</publication><modification>2025-04-18T17:17:25.34Z</modification><creation>2019-03-27T02:03:51Z</creation></dates><accession>S-EPMC1856519</accession><cross_references><pubmed>16118352</pubmed><doi>10.1136/gut.2004.062729</doi></cross_references></HashMap>